carbostyril has been researched along with Clostridioides difficile Infection in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Andremont, A; Assob, CN; Barbut, F; Dayomo, A; Djoko, AB; Djuikoue, IC; Kakam, C; Lacmago, S; Makoudjou, D; Nanfack, A; Njajou, O; Sipowo, RT; Sokeng, V; Tambo, E; Tassadjo, F; Tazemda, G; Tomi, C; Wandji, M | 1 |
Cai, L; Feng, P; Liu, X; Wang, X; Yang, J; Zhang, X; Zong, Z | 1 |
Arpi, M; Boel, JB; Bøggild, N; Gjørup, I; Hansen, SW; Jarløv, JO | 1 |
Chen, YH; Hsueh, PR; Huang, CH; Lai, CC | 1 |
Dzierba, AL; Gershengorn, HB; Keene, A; Wunsch, H | 1 |
Nau, JY | 1 |
Cheek, E; Citron, DM; Cubbon, M; Gerding, DN; Lippett, S; Llewelyn, M; Price, J; Sambol, SP | 1 |
Borgmann, S; Gruber, H; Jakobiak, T; Kist, M; Reil, M; Sagel, U; Schroder, H | 1 |
1 review(s) available for carbostyril and Clostridioides difficile Infection
Article | Year |
---|---|
The potential role of nemonoxacin for treatment of common infections.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Clostridium Infections; Community-Acquired Infections; Drug Therapy, Combination; Gonorrhea; Humans; Levofloxacin; Pneumonia, Bacterial; Quinolones; Skin Diseases, Bacterial | 2015 |
7 other study(ies) available for carbostyril and Clostridioides difficile Infection
Article | Year |
---|---|
Evaluation of inpatients Clostridium difficile prevalence and risk factors in Cameroon.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Bacterial Proteins; Bacterial Toxins; Cameroon; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Diarrhea; Enterotoxins; Feces; Female; Glutamate Dehydrogenase; Humans; Immunoassay; Inpatients; Male; Middle Aged; Prevalence; Quinolones; Young Adult | 2020 |
Antimicrobial susceptibility of Clostridium difficile isolates from ICU colonized patients revealed alert to ST-37 (RT 017) isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Enterotoxins; Fluoroquinolones; Humans; Intensive Care Units; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Quinolones | 2017 |
[Antibiotic stewardship has been established at Herlev Hospital].
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Cephalosporins; Clostridium Infections; Cross Infection; Drug Prescriptions; Drug Utilization Review; Hospitals; Humans; Medical Audit; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinolones | 2014 |
The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Clostridium Infections; Cohort Studies; Colitis; Female; Hospital Costs; Hospital Mortality; Humans; Legionellosis; Length of Stay; Male; Middle Aged; Quinolones; Retrospective Studies; Treatment Outcome; United States; Young Adult | 2015 |
[Cystic Fibrosis: toward a genetic treatment; Clostridium difficile versus Clostridium difficile].
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Biomarkers; Clostridioides difficile; Clostridium Infections; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Therapy, Combination; Humans; Mutation; Quinolones; Spores, Bacterial; Treatment Outcome | 2015 |
Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Doxycycline; Drug Utilization; Health Services Research; Hospitals; Humans; Infection Control; Organizational Policy; Prevalence; Quinolones | 2010 |
Association of ciprofloxacin prescriptions to outpatients to Clostridium difficile infections.
Topics: Anti-Infective Agents; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Contraindications; Germany; Humans; Outpatients; Quinolones | 2010 |